Skip to content
  • Contact Us
CCR Medical
  • Make an Appointment
  • About Us
  • FAQs
  • Contact Us
  • 1-412-662-0095
CCR Medical is now offering Evusheld injections for the immune compromised population.  For more information or to see if you qualify please email or call using the buttons below.
Email Us Call Us
Visit here for Monoclonal Antibody Therapy for COVID
Appointment
BEBTELOVIMAB available with us
Appointment
We facilitate Antibody infusion treatment
Appointment

Before making an appointment CCR Medical recommends that you inform your primary care physician if you have tested positive for COVID-19, or have been in direct contact with someone that has. You and your doctor can then make an informed decision regarding receiving a monoclonal antibody infusion. We also recommend following up with your PCP after receiving the therapy, and letting them know how you are feeling.

ARE YOU ELIGIBLE FOR THIS THERAPY?

COVID-19 Monoclonal Antibody Therapy Clinical Decision Tool

Attention: CCR Medical will continue to administer BEBTELOVIMAB per FDA guidelines. We have limited appointments available Monday-Friday. We will be closed on weekends until further notice. Please follow our Facebook page for the most up to date information.

CCR Medical is a HOT COVID environment. We are treating COVID positive, and post COVID exposure patients only. Understand the risk associated with entering a building with COVID positive patients and if you choose to receive an infusion, you acknowledge and accept the risk.

*Do you have a positive PCR test or antigen test AND the diagnosis of COVID-19?

Reset

*Have your symptoms started within the last 7 days?

Reset

*Are you symptomatic but not yet progressed to require hospitalization or oxygen therapy (or increase from baseline home oxygen therapy)?

Reset

*Are you exposed to an individual infected with SARS-CoV-2 consistent with close contact criteria per Centers for Disease Control and Prevention (CDC)?

Close contact is anyone who was within 6 feet of an infected person for a total of 15 minutes or more.

Reset

*Are you >40 Kg AND at least 12 years old?

Reset

*Is your patient not fully vaccinated or not expected to mount an adequate immune response to complete SARS-CoV-2 vaccination (for example, individuals with immunocompromising conditions including those taking immunosuppressive medications)?

Reset
*Which of the following risk factors puts you at high risk for progression to severe disease?
Based on the answer(s) provided, you are ineligible for mAb therapy.
Based on the answer(s) provided, you are ineligible for mAb therapy.
Based on the answer(s) provided, you are ineligible for mAb therapy.
Based on the answer(s) provided, you are ineligible for mAb therapy.
Based on the answer(s) provided, you are ineligible for mAb therapy.
Based on the answer(s) provided, you are ineligible for mAb therapy.
Based on your above response, you are eligible for this therapy

News and Health Tips

8 Feb

Advantage of BEBTELOVIMAB

Bebtelovimab (LY-CoV1404; LY3853113) is a neutralizing IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2 that maintains binding and neutralizing activity across currently known and reported variants of concern, including Omicron and BA.2.Feb 11, 202284) or visit GSK MedInfo.

Read More
12 Oct

Precaution to COVID

Check with your local health authority for the most relevant guidance for your region. Regular hand washing Covering mouth and nose when coughing and sneezing If you are taking care of someone who is sick, try to stay 6 feet away – this is the distance virus-containing droplets can travel through a sneeze or cough…

Read More
12 Oct

Next generation vaccine platforms for COVID-19

The main benefit of next-generation vaccines is that they can be settled based on sequence information alone. If the viral protein(s) important to provide protection from infection or disease, and thus for inclusion in a vaccine (that is, the vaccine antigen), is known the availability of coding sequences for this viral protein(s) serves to start…

Read More

Our Clinic Address

CCR Medical, 

400 Regis Ave.

Pittsburgh, PA 15236

Call: 1-412-662-0095

Fax: 1-724-371-9116

E-mail: office@ccr-medical.com

© All right reserved 2021

Please Read & Agree

Please make every effort to arrive at your designated appointment time.  If you arrive more than 10 minutes early you may be asked to wait in your vehicle until your appointment time.  If you are more than 15 minutes late, we may have to reschedule your appointment if we are not able to accommodate you at the time you arrive.

Family is not permitted to stay in the building during your appointment.  There are circumstances in which individuals will need to be accompanied by family or caregiver, those situations will be assessed at the discretion of our clinical staff.  Children under the age of 12 or children not being treated are not permitted to come with you to your appointment.

EFFECTIVE JANUARY 1, 2022 – CARES ACT FUNDS HAVE RUN OUT

RELATED TO RECENT CHANGES IN GOVERNMENT FUNDING FOR COVID-19, WE ARE NO LONGER ABLE TO ACCEPT INSURANCE FOR MONOCLONAL ANTIBODY TREATMENT.

THERE WILL BE A $350 ADMINISTRATION FEE THAT MEDICARE HAS SET AS A BASIS FOR PROVIDERS.  THIS FEE IS FOR ALL PATIENTS AND IS DUE AT THE TIME OF YOUR APPOINTMENT. WE ACCEPT CASH, DEBIT CARDS, DISCOVER, VISA AND MASTERCARD.  WE WILL PROVIDE A DETAILED RECEIPT OF SERVICES FOR YOU TO SUBMIT TO YOUR INSURANCE COMPANY FOR REIMBURSEMENT.  WE CAN NOT GUARANTEE THAT YOUR INSURANCE PROVIDER WILL REIMBURSE YOUR PAYMENT.

WE APOLOGIZE FOR THE INCONVENIENCE AS WE NAVIGATE THROUGH THESE CHALLENGES.

CCR Medical is currently providing bebtelovimab – the only currently EUA approved monoclonal antibody for the treatment of COVID-19.  Guidelines for bebtelovimab can be found here: https://pi.lilly.com/eua/bebtelovimab-eua-factsheet-hcp.pdf

CCR Medical is also providing Evusheld – a 6 month prophylactic monoclonal antibody for immune compromised patients.  Guidelines for Evusheld can be found here: https://www.fda.gov/media/154701/download

Before making an appointment CCR Medical recommends that you inform your primary care physician if you have tested positive for COVID-19, or have been in direct contact with someone that has. You and your doctor can then make an informed decision regarding receiving a monoclonal antibody infusion. We also recommend following up with your PCP after receiving the therapy, and letting them know how you are feeling.

Please visit the FAQs tab for all of the information you will need to know prior to your appointment.